Catch T Cells
Embryonal Sarcoma of the Liver
Baylor College of MedicineCell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 28/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Embryonal Sarcoma of the Liver cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Sc-Car.Gpc3Xil15.21 Car T Cells Seattle Children's Hospital | Phase 1 | CC |
21.15.gpc3-car t cells Baylor College of Medicine | Phase 1 | CC |
Same molecule, other indications
Catch T Cells is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →